Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crave-NX is a homeopathic oral spray formulated to provide temporary relief from cravings associated with tobacco, alcohol, and sweets. Developed by NX Gen, the product contains a synergistic blend of highly diluted homeopathic ingredients, including *Lobelia inflata*, *Nux vomica*, and *Tabacum*. These components are traditionally used in homeopathic medicine to address the physical and psychological symptoms of withdrawal and addictive urges. The sublingual spray delivery system is intended to promote rapid absorption through the oral mucosa. As a homeopathic preparation, Crave-NX operates on the principle of "like cures like," aiming to stimulate the body's innate regulatory systems to manage cravings without the use of conventional pharmacological stimulants or nicotine replacement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Crave-NX.